Texas Children's Hospital Pavilion For Women — Houston, Texas

Texas Children's Hospital Pavilion For Women is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Texas Children's Hospital Pavilion For Women has participated in 8 clinical trials with 2 currently active.

Therapeutic areas: Twin to Twin Transfusion, Fertility Preservation, Twin Monochorionic Diamniotic Placenta.

Sponsors: Baylor College of Medicine, Michael A Belfort.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Children's Hospital Pavilion For Women?

Texas Children's Hospital Pavilion For Women has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Children's Hospital Pavilion For Women conducted?

Texas Children's Hospital Pavilion For Women has 8 clinical trials on record, with 2 currently active. Their work covers Twin to Twin Transfusion, Fertility Preservation, Twin Monochorionic Diamniotic Placenta.

Is Texas Children's Hospital Pavilion For Women accredited by Crixeo Clinical Trials?

Texas Children's Hospital Pavilion For Women has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Children's Hospital Pavilion For Women?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.